{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:06:59Z","timestamp":1788883619909,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000288","name":"The Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103058","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:28:43Z","timestamp":1786577323000},"page":"103058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sub-stoichiometric 5-methoxyuridine modification enables tunable immune evasion and protein expression from synthetic mRNAs"],"prefix":"10.1016","volume":"37","author":[{"given":"Jonathan R.","family":"Miles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Bellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel P.","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Loose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Button","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert G.","family":"Fray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3356-6161","authenticated-orcid":false,"given":"Nathan","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103058_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s12276-022-00757-5","article-title":"RNA therapy: rich history, various applications and unlimited future prospects","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtn.2026.103058_bib2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103058_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.omtn.2026.103058_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh1334","article-title":"mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria","volume":"16","author":"Gurung","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.103058_bib5","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41591-021-01573-6","article-title":"A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus","volume":"27","author":"August","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.103058_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymthe.2025.09.041","article-title":"Designing nucleic acid-based therapeutics for cancer treatment: Updates on the state of the art","volume":"34","author":"Peng","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103058_bib7","article-title":"mRNA Based Therapeutics \u2013 Advances and Perspectives","volume":"81","author":"Sergeeva","year":"2016"},{"key":"10.1016\/j.omtn.2026.103058_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.103058_bib9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mrna yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103058_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103058_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N1-methylpseudouridine-incorporated mrna outperforms pseudouridine-incorporated mrna by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.103058_bib12","doi-asserted-by":"crossref","first-page":"e00833-16","DOI":"10.1128\/mBio.00833-16","article-title":"RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling","volume":"7","author":"Durbin","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2026.103058_bib13","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mrna enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103058_bib14","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/nar\/gkac122","article-title":"CMTR1 is recruited to transcription start sites and promotes ribosomal protein and histone gene expression in embryonic stem cells","volume":"50","author":"Liang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103058_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41467-022-28549-5","article-title":"CMTr cap-adjacent 2\u2032-O-ribose mRNA methyltransferases are required for reward learning and mRNA localization to synapses","volume":"13","author":"Haussmann","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103058_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acschembio.0c00864","article-title":"Structural Insights into the Interaction of Clinically Relevant Phosphorothioate mRNA Cap Analogs with Translation Initiation Factor 4E Reveal Stabilization via Electrostatic Thio-Effect","volume":"16","author":"Warminski","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2026.103058_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/frnar.2024.1485307","article-title":"The expanding role of cap-adjacent modifications in animals","volume":"2","author":"Bellows","year":"2024","journal-title":"Front. RNA Res."},{"key":"10.1016\/j.omtn.2026.103058_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41541-025-01153-6","article-title":"Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2","volume":"10","author":"Felgner","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103058_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N 1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103058_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68617-y","article-title":"1m\u03a8 influences the performance of various positive-stranded RNA virus-based replicons","volume":"14","author":"Miyazato","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103058_bib21","doi-asserted-by":"crossref","first-page":"D303","DOI":"10.1093\/nar\/gkx1030","article-title":"MODOMICS: a database of RNA modification pathways. 2017 update","volume":"46","author":"Boccaletto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103058_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102737","article-title":"Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors","volume":"36","author":"Wang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103058_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41467-025-67331-1","article-title":"mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma","volume":"17","author":"Shi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103058_bib24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103058_bib25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41587-024-02306-z","article-title":"Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency","volume":"43","author":"McGee","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103058_bib26","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1093\/nar\/gks426","article-title":"Hydrogen bond formation between the naturally modified nucleobase and phosphate backbone","volume":"40","author":"Sheng","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103058_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf496","article-title":"A flexible, high-throughput system for studying live mRNA translation with HiBiT technology","volume":"53","author":"Ascanelli","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103058_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/acs.bioconjchem.6b00090","article-title":"Effects of chemically modified messenger RNA on protein expression","volume":"27","author":"Li","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2026.103058_bib29","article-title":"Exceptional Uptake, Limited Protein Expression: Liver Macrophages Lost in Translation of Synthetic mRNA","volume":"12","author":"Lin","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.103058_bib30","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/s41467-023-41354-y","article-title":"mRNA vaccine quality analysis using RNA sequencing","volume":"14","author":"Gunter","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103058_bib31","article-title":"Accurate detection of M6A RNA modifications in native RNA sequences","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103058_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41132-w","article-title":"Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation","volume":"14","author":"Jin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103058_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads6498","article-title":"Effective recognition of double-stranded RNA does not require activation of cellular inflammation","volume":"11","author":"Drazkowska","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.103058_bib34","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41590-026-02429-2","article-title":"2\u2032-O-Methyl-guanosine RNA fragments antagonize TLR7 and TLR8 to limit autoimmunity","volume":"27","author":"Alharbi","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2026.103058_bib35","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.vaccine.2016.05.046","article-title":"Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity","volume":"34","author":"Kowalczyk","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2026.103058_bib36","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.ymthe.2025.09.011","article-title":"Immunology of RNA-based vaccines: The critical interplay between inflammation and expression","volume":"33","author":"Tregoning","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103058_bib37","doi-asserted-by":"crossref","first-page":"D303","DOI":"10.1093\/nar\/gkx1030","article-title":"MODOMICS: A database of RNA modification pathways. 2017 update","volume":"46","author":"Boccaletto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103058_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103058_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06936-1","article-title":"Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes","volume":"9","author":"Veiga","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103058_bib40","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1105\/tpc.108.058883","article-title":"MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor","volume":"20","author":"Zhong","year":"2008","journal-title":"Plant Cell"},{"key":"10.1016\/j.omtn.2026.103058_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nature20577","article-title":"M6 A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination","volume":"540","author":"Haussmann","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103058_bib42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1261\/rna.079615.123","article-title":"The importance of m6A topology in chicken embryo mRNA; a precise mapping of m6A at the conserved chicken \u03b2-actin zipcode","volume":"29","author":"Baron","year":"2023","journal-title":"RNA, rna.079615"},{"key":"10.1016\/j.omtn.2026.103058_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0300-9084(96)88118-1","article-title":"Mobilities of modified ribonucleotides on two-dimensional cellulose thin-layer chromatography","volume":"77","author":"Keith","year":"1995","journal-title":"Biochimie"},{"key":"10.1016\/j.omtn.2026.103058_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.102033","article-title":"Protocol for the analysis of double-stranded RNAs in virus-infected insect cells using anti-dsRNA antibodies","volume":"4","author":"de Faria","year":"2023","journal-title":"STAR Protoc."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:44Z","timestamp":1788880424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126002295"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103058","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sub-stoichiometric 5-methoxyuridine modification enables tunable immune evasion and protein expression from synthetic mRNAs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103058"}}